Body mass index as a predictor of hepatic steatosis in living liver donors. - Wikidata - awgldk - TriplyDB

Body mass index as a predictor of hepatic steatosis in living liver donors.

Body mass index as a predictor of hepatic steatosis in living liver donors.

http://www.wikidata.org/entity/Q40708465

about

Outcomes of donor evaluation in adult-to-adult living donor liver transplantation The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Data from a randomized and controlled trial of LCarnitine prescription for the treatment for Non- Alcoholic Fatty Liver Disease.Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts.Utilization of expanded criteria donors in liver transplantation.Hepatic steatosis and its relationship to transplantation.Segment 4 and the left lateral segment regeneration pattern after resection of the middle hepatic vein in a living donor right hepatectomy Review article: adult-to-adult right hepatic lobe living donor liver transplantation.Visceral abdominal and subfascial femoral adipose tissue have opposite associations with liver fat in overweight and obese premenopausal caucasian women The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection.Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation Clinical features and risk factors of patients with fatty liver in Guangzhou area.Suramin decreases injury and improves regeneration of ethanol-induced steatotic partial liver grafts Steatosis as a risk factor in liver surgery.Current trends in live liver donation.Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation.Postoperative coagulopathy after live related donor hepatectomy: Incidence, predictors and implications for safety of thoracic epidural catheter.Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased?Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity.Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.The effects of obesity on drug pharmacokinetics in humans.Overweight in liver transplant recipients.Brain death and marginal grafts in liver transplantation Size mismatch in liver transplantation.The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis.8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantation Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect.Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis.Current practice regarding the use of fatty livers: a trans-Atlantic survey.Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.Successful algorithm for selective liver biopsy in the right hepatic lobe live donor (RHLD).The aggressive phenotype revisited: utilization of higher-risk liver allografts.Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients.Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.Living donor liver transplantation: summary of a conference at The National Institutes of Health.Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years.

P2860

Q30417789-3C41BA0A-9E8B-4C68-ACD9-F47C1EA05119 Q30497534-2DE02DC6-53CA-48FE-9CC4-D9FE3948A046 Q30865139-2EC6525F-E059-4831-9196-0C0844D148F4 Q33640327-F7E1A3B4-CBAE-4358-831A-E4C133C31E3A Q33671918-DEB1BB23-03D3-44BF-9462-6EBBDFFF82E8 Q33871968-3189F820-E6F8-42EF-BA43-FAFA858C00E0 Q34633676-4C4A9A56-EF24-4219-A529-99FC0B56BFF8 Q34702114-0481D8A4-9C65-4B64-955C-D2C87A263464 Q34975828-EB37D858-EA10-46F3-B141-E31D21F6DCA7 Q35231804-3A35D4D5-8A50-42DB-A702-EDCFDC8DDE9F Q35598081-384DE8DF-7988-4A2D-B8D5-8A8C789006F0 Q35745702-E09485CA-316D-4406-8E80-5C944DFB9F42 Q36084089-BF252D32-E45E-4F11-9895-7E28D108733C Q36165357-4CF9ED37-1362-4F2B-ADF0-E475F9EE67E7 Q36502602-E7F6D097-3091-480A-BE35-C2906270A4E4 Q36573237-B5784018-63C4-401F-8922-A4E8A21E767B Q36696488-F8A648AC-58E8-4E7E-8C79-35413681BA65 Q36746806-1FC78DAF-F35C-4585-8906-1690E2696C50 Q36969843-0B192382-2896-4969-A761-251B0CC48D23 Q37091215-1B72A260-695F-4D8F-9335-675F6D355D4E Q37148509-181948DC-4A9A-4126-AF8F-C854FFA8747E Q37149405-B11470D6-25F8-47FA-9324-B7D0FAE645E6 Q37394350-594EDACE-0365-49CC-B9BD-9261E7830F53 Q37613628-0F422EAB-4E56-414E-A1CE-97EC9258D54C Q37854751-AD512A10-C6A8-4E27-A755-0E013D99F509 Q38191466-8AB647F6-FC7E-4630-827B-010F4ED1D1B9 Q38515789-9D1DF5C0-E483-4D5C-806E-F31F7B9130D9 Q38913036-9075ECC3-A5D0-402E-8424-36AEF08C859B Q40606091-96A7608A-67BD-479E-A9AE-FA0F114F7536 Q40955377-DB1FDDE1-82DA-4667-92C4-822F754B5D46 Q41096265-242BE7FE-79BE-4FD5-926B-13BDCA1E00CD Q41894348-B46DAF56-CC82-49DE-B580-6876ECFBF2AD Q42677328-1B4F0B77-8C7E-44EA-A99B-713BC6932E45 Q43929239-F2BD911A-6A09-4314-B0F1-836577A6847B Q44236005-F71EE559-DC2A-4F12-8893-11BC76EB8249 Q44321653-24898D98-7EA7-48C6-85D5-31BD2B941C91 Q44327315-84F37EBD-60CE-47C5-9513-01D384D7EA12 Q44508808-4C46A7A5-BF69-40E6-B9D6-E9F6194D7FBA Q44886384-7F0DAE6B-821D-4DEE-A187-84DD5A3B218C Q45269172-FAE218FB-BB89-48BF-9A6A-96827873DB30

P2860

Body mass index as a predictor of hepatic steatosis in living liver donors.

http://www.wikidata.org/entity/Q40708465

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Body mass index as a predictor of hepatic steatosis in living liver donors.

@en

type

label

Body mass index as a predictor of hepatic steatosis in living liver donors.

@en

prefLabel

Body mass index as a predictor of hepatic steatosis in living liver donors.

@en

P1433

Q40708465-9A0018DA-FC94-483D-8234-385243FF4876

P1476

Q40708465-C985FD25-9F07-4247-BDDD-0B73F6F9AA63

P2093

Q40708465-0BDFDCA4-AE1E-4E13-A660-376CE907E06B

Q40708465-22815C45-3D27-4FDF-90AF-C254CA128204

Q40708465-46CB1A22-A12E-490F-B0D1-ACDE4E22EA6F

Q40708465-7A911E17-E8CC-48AD-A8EB-5EC29A428A1D

Q40708465-8408ABB5-B70D-42DF-825A-B748F3F28064

Q40708465-A606FB4C-7429-4F4C-9880-4C7E7554E326

Q40708465-CC3E099C-7915-40A0-BBD3-7630B7C80E46

Q40708465-EE411304-FEC5-4079-9ED9-E69649DABAF7

Q40708465-EE913ACC-4F9E-40F9-8475-A1523815BC60

P2860

Q40708465-022A0BC5-DC01-4A0B-9A55-6F838955F1D7

Q40708465-268DCF21-3F23-4808-B31B-3026DD3C4709

Q40708465-2FAEC215-11E3-4E27-B2CB-DDF474443242

Q40708465-5BAC3C88-3DCE-4793-B060-3439A9A56E83

Q40708465-6CF8F77C-CD63-4723-B834-AACDF8ADBFE9

Q40708465-720FF751-65AC-4CB5-BACE-8BD198FCCC09

Q40708465-7F88467C-B24C-416A-813A-27D27C8C566D

Q40708465-8F46AEF8-9BD5-4BFC-9DD8-8BB24CE3810B

Q40708465-9E4F7AE0-4F16-4729-BC4C-FBEAD4BF078D

Q40708465-A4816F94-A0C9-4FC4-8246-03DCBB782D75

P304

Q40708465-9988DFFD-016A-4972-BB24-546062EDEF7E

P31

Q40708465-23F2DE0E-E075-403D-913C-DCE0CC852556

P356

Q40708465-6DC15816-2CA8-41C1-BD95-29E489BC27BB

P433

Q40708465-C5B44C4D-5FB1-47ED-8CCB-1AFAC22D5229

P478

Q40708465-B20D5C7D-34A5-465F-AE48-643C8B9C165D

P577

Q40708465-DBD94F76-41B3-42BF-B959-35C06C4514D2

P5875

Q40708465-2485C743-1345-40DC-8DB7-804D5C4622D9

P698

Q40708465-5F1FD6D8-E99C-446B-979E-75706D2ECD1D

P356

JLTS.2001.23787

P1433

Liver Transplantation

P1476

Body mass index as a predictor of hepatic steatosis in living liver donors.

@en

P2093

Abecassis M

http://www.w3.org/2001/XMLSchema#string

Alonso E

http://www.w3.org/2001/XMLSchema#string

Blei AT

http://www.w3.org/2001/XMLSchema#string

Flamm SL

http://www.w3.org/2001/XMLSchema#string

Fryer J

http://www.w3.org/2001/XMLSchema#string

Rao S

http://www.w3.org/2001/XMLSchema#string

Rinella ME

http://www.w3.org/2001/XMLSchema#string

Superina R

http://www.w3.org/2001/XMLSchema#string

Whitington P

http://www.w3.org/2001/XMLSchema#string

P2860

Liver fibrosis in overweight patients

Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe.

Primary nonfunction of hepatic allografts with preexisting fatty infiltration.

Raised liver enzymes in asymptomatic patients: investigation and outcome.

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

Body fat topography as an independent predictor of fatty liver.

Hepatic steatosis in liver transplant donors: common feature of donor population?

Hepatic steatosis as a potential risk factor for major hepatic resection.

Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy.

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation.

P304

409-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JLTS.2001.23787

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11988791

http://www.w3.org/2001/XMLSchema#string

P698

11349260

http://www.w3.org/2001/XMLSchema#string